The DOI matches its Crossref record; 247 of the 247 references it cites were found in a registry or an index.
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–247 of 247
Serretti, A., Zanardi, R., Cusin, C., Rossini, D., Lilli, R., Lorenzi, C., Lattuada, E., & Smeraldi, E. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00324-9 · Cited by 55
Lower Plasma Levels of Haloperidol in Smoking Than in Nonsmoking Schizophrenic Patients
Shimoda, K., Someya, T., Morita, S., Hirokane, G., Noguchi, T., Yokono, A., Shibasaki, M., & Takahashi, S. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199906000-00006 · Cited by 55
Takahashi, H. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00056-1 · Cited by 55
Berecz, R., de la Rubia, A., Dorado, P., Fernández‐Salguero, P. M., Dahl, M., & LLerena, A. (2003) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0576-4 · Cited by 54
Non‐linear fluvoxamine disposition
Spigset, O., Granberg, K., Hägg, S., Söderström, E., & Dahlqvist, R. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00670.x · Cited by 54
Yu, Y. W. ‐., Chen, T., Wang, Y.-C., Liou, Y., Hong, C., & Tsai, S. (2003) · Neuropsychobiology · doi:10.1159/000070582 · Cited by 54
Eye movement disturbances in schizophrenia and a polymorphism of catechol-O-methyltransferase gene
RYBAKOWSKI, J. K., Borkowska, A., Czerski, P. M., & Hauser, J. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00245-7 · Cited by 54
Hong, C.-J., Wang, Y.-C., & Tsai, S. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-001-0686-z · Cited by 54
The Multifactorial Presentation of Depression in Acute Care
Thase, M. E. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12084su1c.01 · Cited by 53
Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects
Liu, Z., Cheng, Z., Huang, S., Chen, X., Ouyang, D., Jiang, C., & Zhou, H. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01402.x · Cited by 53
Woo, S., Kim, J., Rha, E., Han, S., Hahn, K., Park, C., & Sohn, J. (2002) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2002.01038.x · Cited by 52
Illi, A., Mattila, K. M., Kampman, O., Anttila, S. A. K., Roivas, M., Lehtimäki, T. J., & Leinonen, E. V. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000088916.02635.33 · Cited by 52
Beta‐1‐adrenergic receptor gene in major depression: Influence on antidepressant treatment response
Zill, P., Baghai, T. C., Engel, R. R., Zwanzger, P., Schüle, C., Minov, C., Behrens, S., Ronald Bottlender, A., Jäger, M., Rupprecht, R., et al. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20017 · Cited by 52
Hong, C., Lin, C., Yu, Y. W. ‐., Chang, S.-C., Wang, S.-Y., & Tsai, S. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200209000-00009 · Cited by 51
Yasui‐Furukori, N., Mihara, K., Kondo, T., Kubota, T., Iga, T., Takarada, Y., de Vries, R., Kaneko, S., & Tateishi, T. (2003) · The Journal of Clinical Pharmacology · doi:10.1177/0091270002239819 · Cited by 51
Segman, R. H., Shapira, Y., Modai, I., Hamdan, A., Zislin, J., Heresco‐Levy, U., Kanyas, K., Hirschmann, S., Karni, O., Finkel, B., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10255 · Cited by 50
Spigset, O., Hedenmalm, K., Dahl, M. L., et al. (1997) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1997.tb09933.x · Cited by 50
Polymorphic debrisoquine oxidation and acute neuroleptic-induced adverse effects
Spina, E., Ancione, M., Rosa, A. E. D., Meduri, M., & Caputi, A. P. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00266363 · Cited by 49
Clomipramine dose-effect study in patients with depression: Clinical end points and pharmacokinetics
Danish University Antidepressant Group (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.99720 · Cited by 49
Eap, C. B., Bender, S., Gastpar, M., et al. (2000) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200004000-00012 · Cited by 47
The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects
Jiang, Z., Shu, Y., Chen, X., Huang, S., Zhu, R., Wang, W., He, N., & Zhou, H. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0445-6 · Cited by 46
Chirality and Drugs Used in Psychiatry: Nice to Know or Need to Know?
Lane, R. M., & Baker, G. B. (1999) · Cellular and Molecular Neurobiology · doi:10.1023/a:1006997731966 · Cited by 45
Morinobu, S., Tanaka, T., Kawakatsu, S., Totsuka, S., Koyama, E., CHIBA, K., Ishizaki, T., & Kubota, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02593.x · Cited by 45
Koyama, E., Tanaka, T., Chiba, K., Kawakatsu, S., Morinobu, S., Totsuka, S., & Ishizaki, T. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199608000-00003 · Cited by 45
Barbhaiya, R. H., Buch, A., & Greene, D. S. (1996) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1996.tb00051.x · Cited by 43
Yokono, A., Morita, S., Someya, T., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200112000-00002 · Cited by 42
Bupropion Plasma Levels and CYP2D6 Phenotype
Pollock, B. G., Sweet, R. A., Kirshner, M., & Reynolds, C. F. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199610000-00010 · Cited by 42
Nyberg, S., Halldin, C., & Dahl, M. (1995) · Psychopharmacology · doi:10.1007/bf02246302 · Cited by 41
Shimoda, K., Someya, T., Morita, S., Hirokane, G., Yokono, A., Takahashi, S., & Okawa, M. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00263-9 · Cited by 40
Leszczyńska-Rodziewicz, A., Czerski, P. M., Kapelski, P., Godlewski, S., Dmitrzak‐Węglarz, M., RYBAKOWSKI, J. K., & Hauser, J. (2002) · Neuropsychobiology · doi:10.1159/000063668 · Cited by 35
Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patients
Lane, H., Hu, O. Y., Jann, M. W., Deng, H.-C., Lin, H.-N., & Chang, W. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)02999-x · Cited by 33
Someya, T., Suzuki, Y., Shimoda, K., Hirokane, G., Morita, S., Yokono, A., Inoue, Y., & Takahashi, S. (1999) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1999.00611.x · Cited by 33
Kirchheiner, J., Sasse, J., Meineke, I., Roots, I., & ller, J. R. B. (2003) · Pharmacogenetics · doi:10.1097/00008571-200312000-00003 · Cited by 30
Self-citationGenetic association analysis of 5-HT6 receptor gene polymorphism (267C/T) with tardive dyskinesia
Ohmori, O., Shinkai, T., Hori, H., & Nakamura, J. (2002) · Psychiatry Research · doi:10.1016/s0165-1781(02)00095-1 · Cited by 29
Kawanishi, C., Hanihara, T., Shimoda, Y., Suzuki, K., Sugiyama, N., Onishi, H., Miyakawa, T., Yamada, Y., & Kosaka, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1275 · Cited by 27
Enantiomeric antidepressant drugs should be considered on individual merit
Baumann, P., & Eap, C. B. (2001) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.336 · Cited by 26
Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation
Serretti, A., Benedetti, F., Colombo, C., Lilli, R., Lorenzi, C., & Smeraldi, E. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00096-7 · Cited by 25
Hong, C., Yu, Y. W. ‐., Lin, C., Song, H., Lai, H., Yang, K., & Tsai, S. (2000) · Neuropsychobiology · doi:10.1159/000026689 · Cited by 24
Schumann, G., Benedetti, F., Voderholzer, U., Kammerer, N., Hemmeter, U., Travers, H., Fiebich, B. L., Holsboer‐Trachsler, E., Berger, T., Seifritz, E., et al. (2001) · Neuropsychobiology · doi:10.1159/000054879 · Cited by 23
Kishida, I., Kawanishi, C., Furuno, T., Matsumura, T., Hasegawa, H., Sugiyama, N., Suzuki, K., Yamada, Y., & Kosaka, K. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200303000-00010 · Cited by 23
Action of Atypical Antipsychotics
Meltzer, H. Y. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.153-a · Cited by 21
Ohara, K., Tanabu, S., Yoshida, K., Ishibashi, K., Ikemoto, K., & Shibuya, H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00154-4 · Cited by 20
Polymorphisms of μ and δ opioid receptor genes and tardive dyskinesia in patients with schizophrenia
Ohmori, O., Shinkai, T., Hori, H., Kojima, H., & Nakamura, J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00188-2 · Cited by 20
Dopamine receptor polymorphisms and drug response in schizophrenia
Scharfetter, J. (2001) · Pharmacogenomics · doi:10.1517/14622416.2.3.251 · Cited by 18
Possible inhibitory effect of diazepam on the metabolism of zotepine, an antipsychotic drug
Kondo, T., Tanaka, O., Otani, K., Mihara, K., Tokinaga, N., Kaneko, S., Chiba, K., & Ishizaki, T. (1996) · Psychopharmacology · doi:10.1007/s002130050091 · Cited by 16
Pharmacokinetics of Fluvoxamine in Relation to CYP2C19 Phenotype and Genotype
Jann, M. W., ZumBrunnen, T. L., Kazmi, Y., VanDenBerg, C. M., H.D. Desai, Weidler, D. J., & Flockhart, D. A. (2002) · Drug metabolism and drug interactions · doi:10.1515/dmdi.2002.19.1.1 · Cited by 13
Overview of antidepressant therapy.
Thase, M. E. (2001) · PubMed · Cited by 8
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“The area has been extensively reviewed (Kirchheiner et al., 2004; Bertilsson, 2007; Crisafulli et al., 2011; Stingl et al., 2012).”
BackgroundConsensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Ingelman-Sundberg, M., Sim, S. C., Gomez, A., & Rodriguez-Antona, C. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.004 · Cited by 1,166
Ingelman-Sundberg, M. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500285 · Cited by 1,108
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Metadata
- Authors
- Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J.
- Venue
- Molecular Psychiatry
- Published
- 2004-03-23
- Volume
- 9
- Issue
- 5
- Pages
- 442-473
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2001657113
- Cited by
- 724
- References
- 247
- FWCI
- 37.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.